Combination of rapamycin and IL-2 increases de novo induction of human CD4+CD25+FOXP3+ T cells
- 30 June 2008
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 30 (4) , 293-302
- https://doi.org/10.1016/j.jaut.2007.12.012
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Regulatory T cells in the prevention of mucosal inflammatory diseases: Patrolling the borderJournal of Autoimmunity, 2007
- Balancing autoaggressive and protective T cell responsesJournal of Autoimmunity, 2007
- Conventional T-bet+Foxp3− Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infectionThe Journal of Experimental Medicine, 2007
- Transient expression of FOXP3 in human activated nonregulatory CD4+ T cellsEuropean Journal of Immunology, 2006
- Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivoJournal of Clinical Investigation, 2006
- CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cellsThe Journal of Experimental Medicine, 2006
- Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cellsThe Journal of Experimental Medicine, 2006
- Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell developmentProceedings of the National Academy of Sciences, 2006
- Sequential development of interleukin 2–dependent effector and regulatory T cells in response to endogenous systemic antigenThe Journal of Experimental Medicine, 2005
- Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cellsBlood, 2005